Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

226 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients.
Hvid-Jensen F, Pedersen L, Funch-Jensen P, Drewes AM. Hvid-Jensen F, et al. Aliment Pharmacol Ther. 2014 May;39(9):984-91. doi: 10.1111/apt.12693. Epub 2014 Mar 11. Aliment Pharmacol Ther. 2014. PMID: 24617286
Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain.
Krarup AL, Ny L, Astrand M, Bajor A, Hvid-Jensen F, Hansen MB, Simrén M, Funch-Jensen P, Drewes AM. Krarup AL, et al. Aliment Pharmacol Ther. 2011 May;33(10):1113-22. doi: 10.1111/j.1365-2036.2011.04629.x. Epub 2011 Mar 16. Aliment Pharmacol Ther. 2011. PMID: 21410733 Clinical Trial.
An endoscopic method for thermal and chemical stimulation of the human oesophagus.
Olesen SS, Olesen AE, Gravesen F, Poulsen JL, Funch-Jensen P, Gregersen H, Drewes AM. Olesen SS, et al. Neurogastroenterol Motil. 2009 Dec;21(12):1250-e116. doi: 10.1111/j.1365-2982.2009.01362.x. Epub 2009 Jul 13. Neurogastroenterol Motil. 2009. PMID: 19614869
Multimodal pain stimulations in patients with grade B oesophagitis.
Drewes AM, Reddy H, Pedersen J, Funch-Jensen P, Gregersen H, Arendt-Nielsen L. Drewes AM, et al. Gut. 2006 Jul;55(7):926-32. doi: 10.1136/gut.2005.067769. Epub 2005 Aug 9. Gut. 2006. PMID: 16091554 Free PMC article.
Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus--authors' reply.
Hvid-Jensen F, Drewes AM, Funch-Jensen P. Hvid-Jensen F, et al. Aliment Pharmacol Ther. 2014 Oct;40(7):860-1. doi: 10.1111/apt.12931. Aliment Pharmacol Ther. 2014. PMID: 25185739 No abstract available.
Letter: proton pump inhibitors, GERD and oesophageal adenocarcinoma - authors' reply.
Hvid-Jensen F, Funch-Jensen P, Drewes AM. Hvid-Jensen F, et al. Aliment Pharmacol Ther. 2014 Aug;40(3):320. doi: 10.1111/apt.12847. Aliment Pharmacol Ther. 2014. PMID: 25040747 No abstract available.
Identifying responders to acid suppression in dyspepsia using a random starting day trial.
Bytzer P, Hansen JM, Rune S, Bonnevie O, Breinstrup H, Funch-Jensen P, Matzen P, Meineche-Schmidt V, Schaffalitzky De Muckadell OB. Bytzer P, et al. Aliment Pharmacol Ther. 2000 Nov;14(11):1485-94. doi: 10.1046/j.1365-2036.2000.00866.x. Aliment Pharmacol Ther. 2000. PMID: 11069320 Clinical Trial.
Risk of peptic ulcer, oesophagitis, pancreatitis or gallstone in patients with unexplained chest/epigastric pain and normal upper endoscopy: a 10-year Danish cohort study.
Munk EM, Drewes AM, Gorst-Rasmussen A, Gregersen H, Funch-Jensen P, Nørgård B. Munk EM, et al. Aliment Pharmacol Ther. 2007 May 15;25(10):1203-10. doi: 10.1111/j.1365-2036.2007.03315.x. Aliment Pharmacol Ther. 2007. PMID: 17451566
Esophagogastric junction distensibility in hiatus hernia.
Lottrup C, McMahon BP, Ejstrud P, Ostapiuk MA, Funch-Jensen P, Drewes AM. Lottrup C, et al. Dis Esophagus. 2016 Jul;29(5):463-71. doi: 10.1111/dote.12344. Epub 2015 Mar 19. Dis Esophagus. 2016. PMID: 25789842
Severe destruction of esophageal nerves in a patient with achalasia secondary to gastric cancer. A possible role of eosinophil neurotoxic proteins.
Fredens K, Tøttrup A, Kristensen IB, Dahl R, Jacobsen NO, Funch-Jensen P, Thommesen P. Fredens K, et al. Dig Dis Sci. 1989 Feb;34(2):297-303. doi: 10.1007/BF01536066. Dig Dis Sci. 1989. PMID: 2464464
226 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page